|
An angiodynamics territory manager reported an issue with an angiovac c180 with obturator p.During a procedure, the physician noticed a small dot in ivc.The angiovac cannula was removed from the patient and one missing radiopaque marker from one of the oversheath pedal, was located in the patient.The physician continued to use the cannula and attempted to remove the dot from the ivc but were unsuccessful; however, there was no concern with leaving the marker in situ.The procedure was completed, and the patient did not experience any harm or adverse effects as a result of this issue.
|
|
The customer's reported complaint description of ro marker at cannula funnel tip was detached was confirmed during visual inspection of the returned cannula complaint sample.A device history record (dhr) review of the packaging/assembly lots revealed no quality related issues or manufacturing deficiencies at the time of manufacture.There have been no other reported complaints for the indicated packaging/assembly lots for similar ro marker band detached issue.This is the only reported complaint for ro marker band detached failure mode for the angiovac product family in the past 15 months., as such, this is deemed to be an isolated incident.(b)(6) and the complaint sample was sent to contract manufacturer, nordson medical, for product evaluation/root cause determination and dhr review of the reported lot number.Scar response states the detachment of the ro marker is unlikely to be a manufacturing non-conformance due to process controls in place.Dhr review showed that product passed all required inspections and quality controls.Labeling review: the directions for use (dfu) that is provided with this device contains the following statements: warnings: - selection of the patient as a candidate for use with this device and for such procedures as it is intended is the physicians' sole responsibility.The outcome is dependent on many variables including, patient pathology, surgical procedure, and perfusion procedure/technique.The benefits of use of this device must be weighed against the risks including risks of systemic anticoagulation and must be assessed by the prescribing physician.- as with all medical devices, this device and ancillary equipment are to be used by trained physicians only.Specifically, this device is to be used only by medical personnel experienced with initiating and monitoring extracorporeal bypass and by physicians trained and experienced using surgical and/or percutaneous (seldinger) vascular access techniques.Adverse events: this device, as do all extracorporeal blood vessel devices, has possible side effects, which include but are not limited to infections, blood loss, thrombus formation, embolic events, vessel, ventricular or valvular damage and complications of percutaneous or surgical insertion techniques.These may occur if the instructions for use are not followed.Possible complications include those normally associated with large bore surgical and/or percutaneous vessel catheterization/cannulation, anticoagulation, extracorporeal circulation and application of intravascular introducer systems which include but are not limited to: - arrhythmias.- distal embolization of thrombus.- pulmonary embolism.- vascular thrombosis.- death.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint continues to be monitored for trends.Reference (b)(4).
|